GRST — Ethema Health Income Statement
0.000.00%
Last trade - 00:00- $3.09m
- $9.88m
- $6.02m
- 42
- 67
- 17
- 36
Annual income statement for Ethema Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.339 | 1.94 | 4.82 | 5.34 | 6.02 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | -11.5 | 1.91 | 4.29 | 6.2 | 7.35 |
| Operating Profit | 11.9 | 0.03 | 0.533 | -0.854 | -1.33 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.08 | -1.85 | 0.407 | 0.614 | -2.17 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.08 | -1.57 | 0.295 | 1.01 | -2.17 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.08 | -1.54 | 0.248 | 1.18 | -2.06 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.03 | -1.64 | 0.15 | 1.13 | -2.06 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -0.001 | 0 | -0 | -0 |